Ariad Pharma (ARIA) Shares Rise as CEO Sees FDA Approval for Leukemia Drug Next Year
Tweet Send to a Friend
Shares of Ariad Pharma (Nasdaq: ARIA) are spiking higher in mid-day trade following a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
